icon
0%

Everest Group Ltd EG - News Analyzed: 10,286 - Last Week: 100 - Last Month: 400

β†— Everest Group Ltd. (EG) Navigates Volatile Biotech Market Amid Major Movements And Leadership Appointments

Everest Group Ltd. (EG) Navigates Volatile Biotech Market Amid Major Movements And Leadership Appointments
Everest Group Ltd (EG) has been in the spotlight recently with several major movements detected in the bio-tech market. Firstly, DAVENPORT & Co LLC and JPMorgan Chase & Co. continue to hold major stakes in the company. Other institutional investors, including First Trust Advisors LP, Russell Investments Group Ltd, and Vestcor Inc, have also increased their EG holdings. However, certain entities such as Swiss National Bank, American Century Companies Inc., and Prana Capital Management LP have reduced their share amounts. Everest also announced the sale of its Canadian Retail Insurance Unit to Wawanesa, a move that has led to valuation questions and prompted a ratings review. The company also declared a dividend of $2.00. Some encouraging news from Everest Group as they have outperformed their competitors, sparking a turnaround in their share performance. Furthermore, they have announced key leadership appointments, with Jason Busti becoming the Head of North America Treaty Reinsurance.

Everest Group Ltd EG News Analytics from Sat, 13 Sep 2025 07:00:00 GMT to Sat, 28 Mar 2026 01:11:49 GMT - Rating 2 - Innovation 3 - Information 5 - Rumor 0

The email address you have entered is invalid.